Toscana Life Sciences Sviluppo

Toscana Life Sciences Sviluppo is a biotechnology company based in Siena, Italy, dedicated to the development of monoclonal antibodies and vaccines against emerging infectious diseases. Operating as the industrial development arm of the Fondazione Toscana Life Sciences, the company utilizes the Monoclonal Antibody Discovery (MAD) Lab platform to identify and characterize potent neutralizing antibodies. Its lead program, MAD0004J08, is a monoclonal antibody developed for the treatment and prevention of COVID-19. The company plays a central role in the Italian life sciences ecosystem, collaborating with government agencies and academic institutions to advance public health solutions. Its expertise spans from early-stage discovery to clinical trial management and manufacturing coordination.